Garner Todd W — SEC insider filings
SEC reporting owner CIK 1726884. 30 insider filings on record with FilingPulse; latest filed 2026-09-23.
Transaction summary — filings shown
Covers all 30 filings on record, filed 2021-01-06 to 2026-09-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 24 legs across 12 filings — 56,864 shares, $5,597,145 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 40.
- Largest priced transaction: sale of 17,926 shares @ $91.10 ($1,633,075) in CONMED Corp, filed 2023-03-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CONMED Corp (CNMD) | Executive Vice President & CFO | 28 | — | 24 legs · 56,864 sh · $5,597,145 | 38 |
| Avantor, Inc. (AVTR) | EVP and CFO | 2 | — | — | 2 |
Insider filings — Garner Todd W
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-23 | 4 | Avantor, Inc. (AVTR) | Grant/award (A): 49,688 @ $0 · Grant/award (A): 138,632 (derivative) @ $0 | EDGAR |
| 2026-09-23 | 3 | Avantor, Inc. (AVTR) | Holdings only — no transactions reported | EDGAR |
| 2025-11-07 | 4 | CONMED Corp (CNMD) | Sale (S): 3,500 @ $43 | EDGAR |
| 2025-11-03 | 4 | CONMED Corp (CNMD) | Option exercise (M): 7,500 @ $0 · Tax withholding (F): 2,164 @ $44 · Option exercise (M): 7,500 (derivative) @ $0 | EDGAR |
| 2025-08-08 | 4 | CONMED Corp (CNMD) | Sale (S): 598 @ $52.45 | EDGAR |
| 2025-04-08 | 4 | CONMED Corp (CNMD) | Grant/award (A): 371 @ $57.37 | EDGAR |
| 2025-03-05 | 4 | CONMED Corp (CNMD) | Grant/award (A): 61,475 (derivative) @ $0 | EDGAR |
| 2024-11-05 | 4 | CONMED Corp (CNMD) | Grant/award (A): 22,727 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | CONMED Corp (CNMD) | Grant/award (A): 227 @ $76.08 | EDGAR |
| 2024-03-05 | 4 | CONMED Corp (CNMD) | Grant/award (A): 44,677 (derivative) @ $0 | EDGAR |
| 2023-08-17 | 4 | CONMED Corp (CNMD) | Sale (S): 1,355 @ $112.00 | EDGAR |
| 2023-04-04 | 4 | CONMED Corp (CNMD) | Grant/award (A): 240 @ $98.67 | EDGAR |
| 2023-03-14 | 4 | CONMED Corp (CNMD) | Option exercise (M): 30,000 @ $50.61 · Sale (S): 1,300 @ $88.78 · Sale (S): 6,849 @ $90.30 · Sale (S): 17,926 @ $91.10 · Sale (S): 3,825 @ $91.95 · Sale (S): 100 @ $92.63 · +1 more | EDGAR |
| 2023-03-03 | 4 | CONMED Corp (CNMD) | Option exercise (M): 1,600 @ $0 · Tax withholding (F): 486 @ $96.16 · Option exercise (M): 1,600 (derivative) @ $0 · Grant/award (A): 32,212 (derivative) @ $0 | EDGAR |
| 2022-12-12 | 4 | CONMED Corp (CNMD) | Option exercise (M): 4,500 @ $50.61 · Sale (S): 4,500 @ $89.31 · Option exercise (M): 4,500 (derivative) @ $0 | EDGAR |
| 2022-07-07 | 4 | CONMED Corp (CNMD) | Grant/award (A): 1 @ $90.97 | EDGAR |
| 2022-06-14 | 4 | CONMED Corp (CNMD) | Sale (S): 2,662 @ $99.79 | EDGAR |
| 2022-04-04 | 4 | CONMED Corp (CNMD) | Grant/award (A): 168 @ $141.12 | EDGAR |
| 2022-03-03 | 4 | CONMED Corp (CNMD) | Option exercise (M): 1,600 @ $0 · Tax withholding (F): 469 @ $144.55 · Option exercise (M): 1,600 (derivative) @ $0 · Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2022-01-05 | 4 | CONMED Corp (CNMD) | Option exercise (M): 2,000 @ $0 · Tax withholding (F): 637 @ $145.86 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2021-10-05 | 4 | CONMED Corp (CNMD) | Sale (S): 58 @ $129.33 · Sale (S): 81 @ $130.13 · Sale (S): 20 @ $131.62 · Sale (S): 32 @ $132.99 · Option exercise (M): 8,400 @ $50.61 · Sale (S): 3,117 @ $129.38 · +5 more | EDGAR |
| 2021-09-17 | 4 | CONMED Corp (CNMD) | Sale (S): 1,131 @ $124.92 | EDGAR |
| 2021-08-16 | 4 | CONMED Corp (CNMD) | Sale (S): 1,350 @ $122.76 | EDGAR |
| 2021-06-22 | 4/A | CONMED Corp (CNMD) | Sale (S): 960 @ $137.04 | EDGAR |
| 2021-06-16 | 4 | CONMED Corp (CNMD) | Sale (S): 960 @ $137.04 | EDGAR |
| 2021-05-18 | 4 | CONMED Corp (CNMD) | Sale (S): 1,257 @ $141.19 · Gift (G): 1,312 @ $0 | EDGAR |
| 2021-04-02 | 4 | CONMED Corp (CNMD) | Grant/award (A): 191 @ $124.06 | EDGAR |
| 2021-03-03 | 4 | CONMED CORP (CNMD) | Option exercise (M): 1,600 @ $0 · Tax withholding (F): 469 @ $122.55 · Option exercise (M): 1,600 (derivative) @ $0 · Grant/award (A): 45,050 (derivative) @ $0 | EDGAR |
| 2021-01-08 | 4/A | CONMED CORP (CNMD) | Tax withholding (F): 650 @ $111.35 | EDGAR |
| 2021-01-06 | 4 | CONMED CORP (CNMD) | Option exercise (M): 2,000 @ $0 · Tax withholding (F): 980 @ $111.35 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-01-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1726884 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs